These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 36401449)
1. Pioglitazone on nonalcoholic steatohepatitis: A systematic review and meta-analysis of 15 RCTs. Zhao Y; Zhao W; Wang H; Zhao Y; Bu H; Takahashi H Medicine (Baltimore); 2022 Nov; 101(46):e31508. PubMed ID: 36401449 [TBL] [Abstract][Full Text] [Related]
2. Statins on nonalcoholic fatty liver disease: A systematic review and meta-analysis of 14 RCTs. Zhou H; Toshiyoshi M; Zhao W; Zhao Y; Zhao Y Medicine (Baltimore); 2023 Jun; 102(26):e33981. PubMed ID: 37390233 [TBL] [Abstract][Full Text] [Related]
3. The effect of vitamin D supplementation on some metabolic parameters in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of 8 RCTs. Chen X; Zhao Y; Zhang R; Zhao Y; Dai L Medicine (Baltimore); 2023 Oct; 102(42):e35717. PubMed ID: 37861495 [TBL] [Abstract][Full Text] [Related]
4. Liraglutide on type 2 diabetes mellitus with nonalcoholic fatty liver disease: A systematic review and meta-analysis of 16 RCTs. Zhao Y; Zhao W; Bu H; Toshiyoshi M; Zhao Y Medicine (Baltimore); 2023 Feb; 102(6):e32892. PubMed ID: 36820578 [TBL] [Abstract][Full Text] [Related]
5. The feasibility of Chinese massage as an auxiliary way of replacing or reducing drugs in the clinical treatment of adult type 2 diabetes: A systematic review and meta-analysis. Zhang X; Cao D; Yan M; Liu M Medicine (Baltimore); 2020 Aug; 99(34):e21894. PubMed ID: 32846852 [TBL] [Abstract][Full Text] [Related]
6. The effects of glucagon-like peptide-1 receptor agonists on glycemic control and anthropometric profiles among diabetic patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials. Nowrouzi-Sohrabi P; Rezaei S; Jalali M; Ashourpour M; Ahmadipour A; Keshavarz P; Akbari H Eur J Pharmacol; 2021 Feb; 893():173823. PubMed ID: 33352183 [TBL] [Abstract][Full Text] [Related]
7. Diabetes drugs for nonalcoholic fatty liver disease: a systematic review. Blazina I; Selph S Syst Rev; 2019 Nov; 8(1):295. PubMed ID: 31783920 [TBL] [Abstract][Full Text] [Related]
8. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE. Bian H; Zhu X; Xia M; Yan H; Chang X; Hu X; Pan B; Guo W; Li X; Gao X Endocr Pract; 2020 Apr; 26(4):444-453. PubMed ID: 31968197 [No Abstract] [Full Text] [Related]
9. Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD. Hadi A; Mohammadi H; Miraghajani M; Ghaedi E Crit Rev Food Sci Nutr; 2019; 59(15):2494-2505. PubMed ID: 29584449 [No Abstract] [Full Text] [Related]
10. The effects of carnitine supplementation on clinical characteristics of patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials. Abolfathi M; Mohd-Yusof BN; Hanipah ZN; Mohd Redzwan S; Yusof LM; Khosroshahi MZ Complement Ther Med; 2020 Jan; 48():102273. PubMed ID: 31987257 [TBL] [Abstract][Full Text] [Related]
11. Pioglitazone improves hepatic mitochondrial function in a mouse model of nonalcoholic steatohepatitis. Kalavalapalli S; Bril F; Koelmel JP; Abdo K; Guingab J; Andrews P; Li WY; Jose D; Yost RA; Frye RF; Garrett TJ; Cusi K; Sunny NE Am J Physiol Endocrinol Metab; 2018 Aug; 315(2):E163-E173. PubMed ID: 29634314 [TBL] [Abstract][Full Text] [Related]
12. Green tea as a safe alternative approach for nonalcoholic fatty liver treatment: A systematic review and meta-analysis of clinical trials. Mansour-Ghanaei F; Hadi A; Pourmasoumi M; Joukar F; Golpour S; Najafgholizadeh A Phytother Res; 2018 Oct; 32(10):1876-1884. PubMed ID: 29947156 [TBL] [Abstract][Full Text] [Related]
13. Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis. Ma YY; Li L; Yu CH; Shen Z; Chen LH; Li YM World J Gastroenterol; 2013 Oct; 19(40):6911-8. PubMed ID: 24187469 [TBL] [Abstract][Full Text] [Related]
14. Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: a pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study. Bell LN; Wang J; Muralidharan S; Chalasani S; Fullenkamp AM; Wilson LA; Sanyal AJ; Kowdley KV; Neuschwander-Tetri BA; Brunt EM; McCullough AJ; Bass NM; Diehl AM; Unalp-Arida A; Chalasani N; Hepatology; 2012 Oct; 56(4):1311-8. PubMed ID: 22532269 [TBL] [Abstract][Full Text] [Related]
15. Effect of Nigella sativa in the treatment of nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials. Tang G; Zhang L; Tao J; Wei Z Phytother Res; 2021 Aug; 35(8):4183-4193. PubMed ID: 33728708 [TBL] [Abstract][Full Text] [Related]
16. Use of metabolic syndrome severity to assess treatment with vitamin E and pioglitazone for non-alcoholic steatohepatitis. Gurka MJ; Mack JA; Chi X; DeBoer MD J Gastroenterol Hepatol; 2021 Jan; 36(1):249-256. PubMed ID: 32506513 [TBL] [Abstract][Full Text] [Related]
17. Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis: A Meta-analysis. Musso G; Cassader M; Paschetta E; Gambino R JAMA Intern Med; 2017 May; 177(5):633-640. PubMed ID: 28241279 [TBL] [Abstract][Full Text] [Related]
18. Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis. Lian J; Fu J Front Endocrinol (Lausanne); 2021; 12():615409. PubMed ID: 33995271 [TBL] [Abstract][Full Text] [Related]
19. Effects of traditional Chinese exercises on blood glucose and hemoglobin A1c levels in patients with prediabetes: A systematic review and meta-analysis. Yu DD; You LZ; Huang WQ; Cao H; Wang FJ; Tang XQ; Fang ZH; Shen GM; Guan YX J Integr Med; 2020 Jul; 18(4):292-302. PubMed ID: 32534937 [TBL] [Abstract][Full Text] [Related]
20. Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes. Bril F; Kalavalapalli S; Clark VC; Lomonaco R; Soldevila-Pico C; Liu IC; Orsak B; Tio F; Cusi K Clin Gastroenterol Hepatol; 2018 Apr; 16(4):558-566.e2. PubMed ID: 29223443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]